8298 Federal Register / Vol. 90, No. 17 / Tuesday, January 28, 2025 / Notices 

8,878 total fuel retailers need to replace 

labels in any given year with an 

approximate five-year life for labels— 

i.e., 1,776 retailers—multiplied by an 

average of two dispensers per retailer) at 

thirty-eight cents for each label (per 

industry sources), is $1,350 ($0.38 × 

1,776 × 2). 

Request for Comment 

Pursuant to section 3506(c)(2)(A) of 

the PRA, the FTC invites comments on: 

(1) whether the disclosure and 

recordkeeping requirements are 

necessary, including whether the 

information will be practically useful; 

(2) the accuracy of our burden estimates, 

including whether the methodology and 

assumptions used are valid; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) ways to minimize the burden of the 

collection of information. 

For the FTC to consider a comment, 

we must receive it on or before March 

31, 2025. Your comment, including your 

name and your state, will be placed on 

the public record of this proceeding, 

including the https://

www.regulations.gov website. 

You can file a comment online or on 

paper. Due to heightened security 

screening, postal mail addressed to the 

Commission will be subject to delay. We 

encourage you to submit your comments 

online through the https://

www.regulations.gov website. 

If you file your comment on paper, 

write ‘‘Alternative Fuels Rule, PRA 

Comment, P085405,’’ on your comment 

and on the envelope, and mail it to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW, Suite 

CC–5610 (Annex J), Washington, DC 

20580. 

Because your comment will become 

publicly available at https://

www.regulations.gov, you are solely 

responsible for making sure that your 

comment does not include any sensitive 

or confidential information. In 

particular, your comment should not 

include any sensitive personal 

information, such as your or anyone 

else’s Social Security number; date of 

birth; driver’s license number or other 

state identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure that your 

comment does not include any sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . is privileged or 

confidential’’—as provided by section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including, in particular, competitively 

sensitive information, such as costs, 

sales statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Comments containing material for 

which confidential treatment is 

requested must (1) be filed in paper 

form, (2) be clearly labeled 

‘‘Confidential,’’ and (3) comply with 

FTC Rule 4.9(c). In particular, the 

written request for confidential 

treatment that accompanies the 

comment must include the factual and 

legal basis for the request, and must 

identify the specific portions of the 

comment to be withheld from the public 

record. See FTC Rule 4.9(c). Your 

comment will be kept confidential only 

if the General Counsel grants your 

request in accordance with the law and 

the public interest. Once your comment 

has been posted publicly at 

www.regulations.gov, we cannot redact 

or remove your comment unless you 

submit a confidentiality request that 

meets the requirements for such 

treatment under FTC Rule 4.9(c), and 

the General Counsel grants that request. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before March 31, 2025. For information 

on the Commission’s privacy policy, 

including routine uses permitted by the 

Privacy Act, see https://www.ftc.gov/ 

site-information/privacy-policy. 

Josephine Liu, 

Assistant General Counsel for Legal Counsel. 

[FR Doc. 2025–01778 Filed 1–27–25; 8:45 am] 

BILLING CODE 6750–01–P 

INTERNATIONAL TRADE 

COMMISSION 

Notice of Receipt of Amended 

Complaint; Solicitation of Comments 

Relating to the Public Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has received an amended 

complaint entitled ‘‘Certain Motorized 

Self-Balancing Vehicles, DN 3801’’; the 

Commission is soliciting comments on 

any public interest issues raised by the 

amended complaint or complainant’s 

filing pursuant to the Commission’s 

Rules of Practice and Procedure. 

FOR FURTHER INFORMATION CONTACT: Lisa 

R. Barton, Secretary to the Commission, 

U.S. International Trade Commission, 

500 E Street SW, Washington, DC 

20436, telephone (202) 205–2000. The 

public version of the complaint can be 

accessed on the Commission’s 

Electronic Document Information 

System (EDIS) at https://edis.usitc.gov. 

For help accessing EDIS, please email 

EDIS3Help@usitc.gov. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server at United 

States International Trade Commission 

(USITC) at https://www.usitc.gov. The 

public record for this investigation may 

be viewed on the Commission’s 

Electronic Document Information 

System (EDIS) at https://edis.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission has received an amended 

complaint and a submission pursuant to 

§ 210.8(b) of the Commission’s Rules of 

Practice and Procedure filed on behalf 

of Razor USA LLC and Shane Chen on 

January 21, 2025. The original 

complaint was filed on January 3, 2025 

and a notice of receipt of complaint; 

solicitation of comments relating to the 

public interest published in the Federal 

Register on January 10, 2025. The 

amended complaint alleges violations of 

section 337 of the Tariff Act of 1930 (19 

U.S.C. 1337) in the importation into the 

United States, the sale for importation, 

and the sale within the United States 

after importation of certain motorized 

self-balancing vehicles. The amended 

complaint names as respondents: Golabs 

Inc. d/b/a Gotrax of Carrollton, TX; 

Dongguan Saibotan Nengyuan Keji Co., 

Ltd. d/b/a ‘‘Gyroor US’’ of China; 

Unicorn Network, LLC d/b/a/Sisigad c/ 

o A Registered Agent, Inc. of Dover, DE; 

Gyroor Technology (CHINA) Co., Ltd. d/ 

b/a Gyroor of China; and Shenzhen 

Chitado Technology Co., Ltd. d/b/a 

Gyroor of China. The complainant 

requests that the Commission issue a 

limited exclusion order, cease and 

desist orders and impose a bond upon 

respondents’ alleged infringing articles 

during the 60-day Presidential review 

period pursuant to 19 U.S.C. 1337(j). 

Proposed respondents, other 

interested parties, members of the 

public, and interested government 

agencies are invited to file comments on 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 90, No. 17 / Tuesday, January 28, 2025 / Notices 8299 

1Handbook for Electronic Filing Procedures: 

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf. 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

any public interest issues raised by the 

amended complaint or § 210.8(b) filing. 

Comments should address whether 

issuance of the relief specifically 

requested by the complainant in this 

investigation would affect the public 

health and welfare in the United States, 

competitive conditions in the United 

States economy, the production of like 

or directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) explain how the articles potentially 

subject to the requested remedial orders 

are used in the United States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the requested remedial 

orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to the requested 

exclusion order and/or a cease and 

desist order within a commercially 

reasonable time; and 

(v) explain how the requested 

remedial orders would impact United 

States consumers. 

Written submissions on the public 

interest must be filed no later than by 

close of business, eight calendar days 

after the date of publication of this 

notice in the Federal Register. There 

will be further opportunities for 

comment on the public interest after the 

issuance of any final initial 

determination in this investigation. Any 

written submissions on other issues 

must also be filed by no later than the 

close of business, eight calendar days 

after publication of this notice in the 

Federal Register. Complainant may file 

replies to any written submissions no 

later than three calendar days after the 

date on which any initial submissions 

were due, notwithstanding § 201.14(a) 

of the Commission’s Rules of Practice 

and Procedure. No other submissions 

will be accepted, unless requested by 

the Commission. Any submissions and 

replies filed in response to this Notice 

are limited to five (5) pages in length, 

inclusive of attachments. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. Submissions should refer 

to the docket number (‘‘Docket No. 

3801’’) in a prominent place on the 

cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, Electronic Filing 

Procedures 1). Please note the 

Secretary’s Office will accept only 

electronic filings during this time. 

Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov.) No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. Persons with questions 

regarding filing should contact the 

Secretary at EDIS3Help@usitc.gov. 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. appendix 3; or (ii) by U.S. 

Government employees and contract 

personnel 2, solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS 3. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: January 23, 2025. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2025–01815 Filed 1–27–25; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1377] 

Certain Products Containing 

Tirzepatide and Products Purporting 

To Contain Tirzepatide; Notice of a 

Commission Determination Not To 

Review an Initial Determination Finding 

Respondents in Violation of Section 

337; Request for Written Submissions 

on Remedy, the Public Interest, and 

Bonding 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission (‘‘Commission’’) has 

determined not to review an initial 

determination (‘‘ID’’) (Order No. 26) of 

the presiding administrative law judge 

(‘‘ALJ’’), partially granting a motion for 

summary determination on violation of 

section 337. The Commission requests 

written submissions from the parties, 

interested government agencies, and 

other interested persons on the issues of 

remedy, the public interest, and 

bonding, under the schedule set forth 

below. 

FOR FURTHER INFORMATION CONTACT: 

Ronald A. Traud, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3427. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on November 27, 2023, based upon a 

complaint filed on behalf of Eli Lilly 

and Company of Indianapolis, Indiana 

(‘‘Lilly’’). 88 FR 82914, 82914–15 (Nov. 

27, 2023). The complaint, as 

supplemented, alleges violations of 

section 337 based upon the importation 

into the United States, the sale for 

importation, and the sale within the 

United States after importation of 

certain products containing tirzepatide 

or purporting to contain tirzepatide by 

reason of false designation of source and 


ddrumheller on DSK120RN23PROD with NOTICES1